CoCites: A citation-based method for searching scientific literature

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.

Karan Seegobin, Umair Majeed, Nathaniel Wiest, Rami Manochakian, Yanyan Lou, Yujie Zhao. Front Oncol 2021
Times Cited: 1

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).

Yuankai Shi, Joseph Siu-Kie Au, Sumitra Thongprasert, Sankar Srinivasan, Chun-Ming Tsai, Mai Trong Khoa, Karin Heeroma, Yohji Itoh, Gerardo Cornelio, Pan-Chyr Yang. J Thorac Oncol 2014
Times Cited: 753

List of shared articles

Times cited

An advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report.
Ronghua Yang, Dong Wang, Xia Li, Kaiping Mao, Jinglong Wang, Peng Li, Xiaoliang Shi, Shanshan Zhang, Yongjie Wang. Ann Transl Med 2022